Company news
ADMA Biologics Inc news in 2022
ADMA Biologics Inc's news releases, calls and decks from 2022, newest first.
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
December 12, 2022
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 8, 2022
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 6, 2022
ADMA Biologics Announces Proposed Public Offering of Common Stock
December 5, 2022
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
December 5, 2022
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 8, 2022
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
November 1, 2022
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
October 30, 2022
ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update
August 9, 2022
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022
August 2, 2022
ADMA Biologics Announces Addition to the Russell 2000® Index
June 20, 2022
ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
May 3, 2022
ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022
March 31, 2022
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months
March 24, 2022
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management
March 23, 2022
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
March 20, 2022
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
March 6, 2022
ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update
January 18, 2022
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC
January 17, 2022